Retatrutide Outperforms Ozempic in Phase 3 Diabetes Trial | Retatrutide News

Retatrutide has shown superior efficacy over Ozempic in controlling blood sugar and promoting weight loss in a Phase 3 diabetes trial. This positions El...
Clinical Trials · November 1, 2026